| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 5 | -64.3K | 100% | $14.29 | -$919K |
| Net | -5 | -64.3K | -100% | -$919K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Peter H. Soderberg | Director | $5.24M | May 17, 2021 | ||
| Daniel L. Reuvers | Director | $3.11M | -$561K | -15.3% | Mar 11, 2025 |
| Sheri Louise Dodd | Chief Executive Officer, Director | $2.41M | Feb 20, 2025 | ||
| Richard Nigon | Director | $2.39M | May 17, 2021 | ||
| Elaine M. Birkemeyer | Chief Financial Officer | $1.48M | -$127K | -7.91% | Feb 25, 2025 |
| Roche Kevin H | Director | $1.36M | Oct 1, 2021 | ||
| Kristie Burns | Sr. VP Mktg & Clinical Affairs | $1.12M | -$176K | -13.6% | Feb 25, 2025 |
| Brent Moen | Chief Financial Officer | $1M | Mar 1, 2023 | ||
| Eric Pauls | Senior VP, Sales | $606K | May 8, 2023 | ||
| Raymond Huggenberger | Director | $578K | May 8, 2024 | ||
| Sherri Lee Ferstler | Senior VP, Sales | $507K | -$20.3K | -3.84% | Aug 12, 2024 |
| William W. Burke | Director | $503K | -$35.2K | -6.54% | May 8, 2024 |
| David Brent Shafer | Director | $471K | May 8, 2024 | ||
| Valerie L. Asbury | Director | $471K | May 8, 2024 | ||
| Deepti Jain | Director | $317K | May 9, 2022 | ||
| Carmen Volkart | Director | $311K | May 8, 2024 | ||
| Boyd Vindell Washington | Director | $275K | May 8, 2024 | ||
| Laura G. King | Director | $38.8K | Feb 20, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|